Streetbeat News

Stock Prices

ASTI

GDDY

LYRA

Ascent Solar Technologies (ASTI) has achieved a new benchmark of 15.5% in cell production efficiency of its CIGS solar technology. Lyra Therapeutics' (LYRA) BEACON Phase 2 study of LYR-220 for chronic rhinosinusitis in patients with prior ethmoid sinus surgery met its primary endpoint. GoDaddy (GDDY) shares are trading higher after Starboard Value sent a letter to the company, stating it believes GoDaddy is deeply undervalued with significant opportunities for shareholder value creation.

Portfolio Pulse from ryanfaloona@benzinga.com

September 12, 2023 | 12:35 pm

BRTX

BioRestorative Therapies Inc (NASDAQ:BRTX) has entered into a supply agreement with Evolutionary Biologics to manufacture tissue-based biologics for cosmetic and aesthetic applications. The initial order of 5,000 vials is expected to have a positive financial impact. The first product is an umbilical cord tissue extract enriched with factors that address signs of aging. Evolutionary Biologics, founded by former L'Oreal President Jim Morrison, supplies cosmetic-focused biologics to plastic surgeons, dermatologists, and medical spas in the U.S.

Portfolio Pulse from Vandana Singh

September 12, 2023 | 12:30 pm

SLRN

Acelyrin Inc (NASDAQ:SLRN) announced topline results from a Phase 2b/3 trial evaluating izokibep for moderate-to-severe Hidradenitis Suppurativa (HS). The primary endpoint did not meet statistical significance, but showed early responses and no safety issues. The stock price fell by 58.80% in premarket trading.

Portfolio Pulse from Vandana Singh

September 12, 2023 | 12:28 pm

GDDY

GoDaddy's shares are trading higher following a letter from Starboard Value stating that it believes GoDaddy is deeply undervalued with significant opportunities for shareholder value creation.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:27 pm

AER

AerCap's shares are trading lower after the company priced a secondary offering of 40.66 million ordinary shares by GE Capital US Holdings at $59 per share.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:25 pm

ORCL

Oracle reported mixed Q1 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:23 pm

ALB

CLF

CLFD

OKE

PYPL

RIVN

SAVA

Jim Cramer, on CNBC's 'Mad Money Lightning Round', recommended buying ONEOK, Inc. (OKE) and Trane Technologies plc (TR), but advised against investing in Albemarle Corporation (ALB), PayPal Holdings, Inc. (PYPL), Rivian Automotive, Inc. (RIVN), and Clearfield, Inc. (CLFD). He also mentioned that Cassava Sciences, Inc. (SAVA) is a high-risk, high-reward investment, and suggested waiting to invest in Cleveland-Cliffs Inc. (CLF).

Portfolio Pulse from Lisa Levin

September 12, 2023 | 12:21 pm

ACLS

Axcelis Technologies, Inc. (ACLS) has announced an additional $200 million funding for its share repurchase program. This move is expected to return value to shareholders and shows the company's confidence in its future growth.

Portfolio Pulse from Bill Haddad

September 12, 2023 | 12:20 pm

INDA

India's Consumer Price Index (CPI) for August was reported at 6.83%, lower than the estimated 7% and the prior figure of 7.44%.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:19 pm

USO

OPEC has maintained its 2024 non-OPEC supply-growth forecast at 1.4 million barrels per day (B/D), while increasing its 2023 non-OPEC supply-growth forecast by 100,000 B/D to 1.6 million B/D.

Portfolio Pulse from Bill Haddad

September 12, 2023 | 12:18 pm